uniQure N.V.

Home » uniQure N.V.

Secondary

uniQure N.V.

We are a leader in the field of gene therapy, seeking to develop single treatments with potentially curative results for patients suffering from genetic and other devastating diseases.

Symbol

QURE

Last Closing Price
$28.50

Shares
4,500,000

Anticipated Date
TBD

Underwriters
Leerink Partners, Evercore ISI, Wells Fargo Securities

To view the prospectus for uniQure N.V., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253